Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by quest13on Feb 18, 2022 1:33pm
206 Views
Post# 34442594

RE:Vertex and Witkowski Partnership

RE:Vertex and Witkowski PartnershipI see nothing that I would find unusual here.

Dr. Witkowski has been reporting on his website that he is very interested in carrying out transplant into the portal vein and he has commented that being unable to do so in the USA was something he was very much disturbed by.

He seems to have been successful in getting permission to do what I will call the "Edmonton protocol" or the long available Portal vein since it is very similar to what I have read of it. That Vertex was able to get permission to use stem cells to do a trial is very good news for sufferers. I also note that there is quite a bit said about drugs required and I also wonder if there are rejection worries. In any case we SVA have the pouch with a stable home for Cells to be placed into where they can survice happily.

I think it will light a fire under whoever SVA is working with to get permission for either their Conformal coating or some stem cell derived non immune attack subject cells. I find the time that has passed to be very long since we saw the first successful report in January of 2021 

The whole thing as I see it is that the medical profession wants desperately to enter cells into humans to see if they work properly once placed and that the FDA approves whatever is the successful method.

I still see the Pouch system having immense benefits in providing a home for the cells and I believe SVA will be seen to have the best system - At least I hope so as well for my investment
<< Previous
Bullboard Posts
Next >>